Search Results for: Cipla

Sensex, Nifty open on positive note but turn negative soon

Though opened on a positive note, Sensex by 10:50 a.m. reached 57,310, down by 321 points, continuing the downward trend

Feb 8, 2022

Sensex down, loses 978 points in just one hour

At 10.25 a.m., Sensex traded at 56,879 points, down 978 points, whereas Nifty at 16,970 points, down 307 points.

Jan 27, 2022

Sensex, Nifty witness a sharp decline as markets open, 5th straight session in decline

This is the fifth consecutive decline in sessions for Sensex, down 1.1 per cent or 635 points on Monday at 11:30 am

Jan 24, 2022

Equities gain for fourth straight session; Sensex up over 500 pts [details]

On Wednesday, the Sensex and Nifty settled at 61,150 points and 18,212 points, traded in the green for the fourth consecutive session.

Jan 12, 2022

Sensex opens in green zone; Q3FY22 earnings in focus for fresh cues

At 10:13 a.m., Sensex traded at 60,972 points, up 0.6 per cent from its previous close of 60,616 points though it opened at 61,014 points

Jan 12, 2022

Sensex, Nifty trade positive in first trading session of the year 2022

The 30-scrip Sensitive Index (Sensex) and broader 50-scrip Nifty at the National Stock Exchange (NSE) traded in the green in early trade on Monday -- the first trading session in 2022.

Jan 3, 2022

Sensex, Nifty up during early trade on Tuesday; JSW Steel, Hindalco, others top gainers

During the early trade on Tuesday, the 30-scrip Sensex rose higher. While prominent companies gained, pharma stocks like Cipla were among the losers.

Dec 7, 2021

Sensex rises for third consecutive day, trading around 58K points

Sensex is trading at 58,671 points, showing signs of rise for the third consecutive day though it may take time to reach above 60K range amid Omicron fears

Dec 3, 2021

Sensex dovetails by 1,687 pts as new Covid surge reports surface; Paytm recovers slightly

Sensex closed at 57,107 points, down by 1,687 points, while the broader 50-scrip Nifty closed the day at 17,026 points, down by 509 points. Paytm slightly recovered after a disappointing debut last week

Nov 26, 2021

Covid vaccine news: Not two, but five different coronavirus jabs will be available in India

The central government is expected to start importing the coronavirus vaccine developed by Pfizer soon

Jun 29, 2021

Covid treatment: Indian doctors administer cocktail medication to patients [details]

Indian doctors are giving this cocktail medications to people who have mild to moderate Covid symptoms

Jun 1, 2021

What is Covid antibody cocktail: How does Roche, Cipla drug work and pricing

The price for each patient dose, which has a combined dose of 1200 mg (600 mg of Casirivimab and 600 mg of Imdevimab), will be Rs 59,750.

May 25, 2021

Medicines, consumables crucial for COVID treatment depleting fast; B'luru doctor sounds alarm

While the focus is on Remdesivir and oxygen shortage, hospitals are now running out of other important medicines and consumables used in the treatment of COVID patients.

May 14, 2021

Drug firms Cipla, Jubilant resume supplying Remdesivir in Karnataka

Pharma majors Cipla and Jubilant resumed supplying anti-viral drug Remdesivir in Karnataka a day after the state government warned them of legal action if they failed to deliver in 24 hours, said state Revenue Minister R. Ashoka on Wednesday.

May 13, 2021

Ramp up Remdesivir supply; K'taka govt sets 24-hour deadline for Cipla, Jubilant

The state revenue department issued a show cause notice to both the pharma majors for failing to supply the committed quantities of Remdesivir within the stipulated time frame.

May 12, 2021

1 2 3 4 5 6 7 8 9 10 Next